ProfileGDS5678 / 1430602_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 24% 18% 18% 18% 18% 18% 18% 18% 18% 18% 18% 18% 18% 18% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.5882524
GSM967853U87-EV human glioblastoma xenograft - Control 22.4440218
GSM967854U87-EV human glioblastoma xenograft - Control 32.4480218
GSM967855U87-EV human glioblastoma xenograft - Control 42.3885918
GSM967856U87-EV human glioblastoma xenograft - Control 52.3864518
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5039918
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4685618
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4156118
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4070718
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4274318
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4271818
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4052118
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.440618
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4347118